This episode is brought to you by BiOptimizers Magnesium Breakthrough and Calm.
Many people are unaware of the benefits of psychedelics when taken in a controlled, clinical setting under the care of a professional. Emerging research has shown promise for healing from trauma, connecting to your partner, and gaining insight into the bigger picture of consciousness and life itself.
This week on The Dhru Purohit Podcast, Dhru sits down with Rick Doblin, Ph.D., the founder and President of the Multidisciplinary Association for Psychedelics (MAPS), to discuss the use of psychedelics, specifically MDMA, as a therapeutic intervention for qualifying candidates with complex mental illness, schizophrenia, PTSD, anxiety, eating disorders, and more.
Rick Doblin, Ph.D., is the Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on regulating the medical uses of psychedelics and marijuana and his Master’s thesis on smoked marijuana vs. the oral THC pill in nausea control for cancer patients.
Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana as prescription medicines, for the personal growth of otherwise healthy people, and eventually to become a legally licensed psychedelic therapist.
In this episode, Dhru and Rick dive into (audio version / Apple Subscriber version):
-Why it’s so hard to see beyond existence (1:28 / 1:28)
-How Rick’s beliefs and personal views were shaped by his psychedelic experiences (8:19 / 6:58)
-Potential sources of inner wisdom/guidance when taking psilocybin (16:07 / 14:30)
-Idiosyncrasies that caused Rick to pursue psychedelic research (28:50 / 26:42)
-A deep dive into the history of MDMA (35:03 / 32:06)
-Therapeutic uses of MDMA (54:20 / 57:51)
-The effects of psilocybin on the brain (1:10:45 / 1:07:46)
-The war on drugs and how it impacted the public’s perception of psychedelics (1:20:33 / 1:17:32)
-The recent advancements in psilocybin and MDMA for therapeutic use (1:27:20 / 1:24:25)
-Early evidence on the ill effects of marijuana: should we be concerned? (1:30:55 / 1:28:05)
-Current status of MDMA in psychological interventions (1:42 / 1:39:24)
-Future hopes for FDA to allow psychedelic drugs to come to market (1:45:22 / 1:42:04)
Also mentioned in this episode:
-Maui Wild Fires Support/Resources
-Make a donation to MAPS here
-Maps.org
For more on Rick Doblin, follow him on Instagram @rickdoblinphd.
BiOptimizers is offering 10% off + special gift with purchase, just head over to magbreakthrough.com/dhru with code DHRU10.
Calm is offering an exclusive offer of 40% off a Calm Premium Subscription. Head over to calm.com/dhru today.
Hosted on Acast. See acast.com/privacy for more information.
Learn more about your ad choices. Visit megaphone.fm/adchoices
